K. Park

CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?

W. S. Kim, Si Yeol Song, Yong Chan Ahn et al. · Annals of Oncology · 2001 · 202 citations · Full text

Lymphoid Neoplasia, Radiation Medicine, Radiation Therapy +6

A phase II, multicenter, two cohort study of 160 mg osimertinib in EGFR T790M-positive non-small-cell lung cancer patients with brain metastases or leptomeningeal disease who progressed on prior EGFR TKI therapy

Seo‐Young Park, M.-H. Lee, Minjung Seong et al. · Annals of Oncology · 2020 · 185 citations · Full text

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

Hee Jae Jun, Myung‐Ju Ahn, Hyo Song Kim et al. · British Journal of Cancer · 2008 · 149 citations · Full text

Tumor Biology, Surgical Oncology, Squamous Cell Carcinoma +14

Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer

Sung Hee Lim, Min Eui Hong, Sung Woo Ahn et al. · European Journal of Cancer · 2015 · 149 citations

Tumor Biology, Esophageal Cancer, Squamous Oesophageal Cancer +8

HLA-corrected tumor mutation burden and homologous recombination deficiency for the prediction of response to PD-(L)1 blockade in advanced non-small-cell lung cancer patients

Joonho Shim, H.S. Kim, Hongui Cha et al. · Annals of Oncology · 2020 · 145 citations